Global biopharmaceutical company AstraZeneca is gearing up to become the No. 1 provider of cancer drugs, its oncology chief said during the European Society for Medical Oncology’s conference, Bloomberg reported Sept. 11.
Read the full post on Becker's Hospital Review - Healthcare News
